Since the plck-GAPDH mice only develop AITL disease at the age of 2 years or older, we established a mAITL transplant model based on NOD/SCIDγ-/- (NSG) mice to allow preclinical drug testing [8, 10]. This evidence concerns the gene GAPDH and angioimmunoblastic T-cell lymphoma.